Royalty Pharma Sub-Manager, LLC

Position in KLRA — Kailera Therapeutics, Inc.

CIK 2081668 New York, NY

Position in KLRA

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$54,091,514

New position

Shares Held

2,455,357

first reported quarter

Ownership

1.89%

of shares outstanding

% of Portfolio

22.36%

of 13F equity value

Holder Rank

#12

of 98 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Royalty Pharma Sub-Manager, LLC holds $241,917,579 across 4 Biotechnology names. KLRA ranks #3 (22.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	980,392	$83,519,594
2	ZBIO	Zenas BioPharma, Inc.	2,388,150	$60,611,247
3	KLRA	Kailera Therapeutics, Inc. This page	2,455,357	$54,091,514
4	BHVN	Biohaven Ltd.	2,936,507	$43,695,224

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$54,091,514	2,455,357	—	Shares	Defined	2026-08-21
No filing history on record for this holder in this stock.